Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × FED × Myasthenia Gravis × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 44 OTHER 10 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 6 Rare Diseases 2 Carcinoma, Squamous Cell 2 Carcinoma, Basal Cell 2 Skin Neoplasms 1 Polycystic Ovary Syndrome 1 Patient Compliance 1 Neoplasms 1 Myasthenia Gravis 1 Keratosis, Actinic 1 Infertility 1 Hyperandrogenism 1 Gastrointestinal Diseases 1 Fibrosis 1 Erectile Dysfunction 1 Dupuytren Contracture 1 Crohn Disease 1 Connective Tissue Diseases 1 Chronic Disease 1 Carcinoma, Hepatocellular 1 Arthritis 1 Anovulation 1

Interventions

Mycophenolic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00285350 2015-03-25

Mycophenolate Mofetil in Myasthenia Gravis

FDA Office of Orphan Products Development

Phase 3 Completed

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡